Digest Réseau Comment ça marche
Réseau
/
Sociétés
Re
Non vérifié

RevBio, Inc.

Ce que nous écrivons

BiotechnologieHygiène alimentaireIndustrieMédecine naturelle/Médecines DoucesMultimédia

9 communiqués de presse

Voir tous les communiqués de presse
28/01/2026
FDA Greenlights RevBio’s Pivotal Clinical Trial for its Cranial Flap Bone Glue
Source
RevBio, Inc.
Émetteur
Business Wire
1.00
0
22/12/2025
RevBio® Receives Approval from FDA to Start a Dental Clinical Trial for its Regenerative Bone Glue
Source
RevBio, Inc.
Émetteur
Business Wire
1.00
0
04/11/2025
RevBio® Receives First FDA Approval for a "Bone Glue" to Treat Extremity Fractures in a Clinical Trial
Source
RevBio, Inc.
Émetteur
Business Wire
1.00
0
06/10/2025
RevBio Receives a $2.2 Million Phase II NIH Grant to Further Develop the Minimally Invasive Use of TETRANITE® to Treat Complex Spine Fractures
Source
RevBio, Inc.
Émetteur
Business Wire
1.00
0
29/05/2025
RevBio Expands Globally into the United Kingdom with its Second Cranial Flap Fixation Clinical Trial for its Regenerative Bone Adhesive
Source
RevBio, Inc.
Émetteur
Business Wire
1.00
0
17/03/2025
Multimédia
Industrie
Science
Équipement médical et sanitaire
Médecine - Divers
Hygiène alimentaire
Prothèses dentaires
Biotechnologie
Médecine naturelle/Médecines Douces
Santé
RevBio Initiates its Pivotal Clinical Trial in Europe for its Dental Implant Stabilization Product
Source
RevBio, Inc.
Émetteur
Business Wire
1.00
0
30/01/2025
RevBio Issued a Key Patent for its Regenerative Bone Adhesive Technology by the United States Patent and Trademark Office
Source
RevBio, Inc.
Émetteur
Business Wire
1.00
0
11/12/2024
Multimédia
Industrie
Santé Publique
Science
Équipement médical et sanitaire
Médecine - Divers
Biotechnologie
Médecine naturelle/Médecines Douces
Hygiène alimentaire
Santé
RevBio Receives Both FDA Approval to Expand its Clinical Trial and CMS Reimbursement for its Regenerative Bone Adhesive for Cranial Flap Fixation
Source
RevBio, Inc.
Émetteur
Business Wire
1.00
0
16/09/2024
RevBio Receives a $2.4 Million NIH Grant to Conduct a First-in-Human Clinical Trial for its Regenerative Bone Adhesive for Cranial Flap Fixation and Enrolls First Five Patients
Source
RevBio, Inc.
Émetteur
Business Wire
1.00
0

Détails du contact

Réseaux sociaux

Followers
0
Compatibilité
0